Pills although so far the PBM has only dropped five drugs, targets could appear on the backs of other highly expensive drugs as reviews of products continues. (Photo: Getty)

Drugmakers, beware: if you boost the price on your products too much, a pharmacy benefit manager may just kick it off its list of approved formularies as the default option for doctors to prescribe.

That’s what CVS Caremark has started to do, according to Fierce Healthcare, to save its PBM clients bucks. In fact, CVS Caremark estimates that it has saved its PBM clients an average of $15 per 30-day supply on drugs, with clients on its new formulary model paying an average of $88.30 for a 30-day drug supply, compared to $102.58 for other formulary designs.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.